Page 921 - Textbook of Pathology, 6th Edition
P. 921

Lombard DB et al: DNA  repair, genome stability and aging.  Cell  Evans SW, Whicher JT:  The cytokines: physiological and  905
              120:497,2005.                                        pathophysiological aspects. Adv Clin Chem 30: 1, 1993.
           Perls  T,  Terry D: Understanding the determinants of exceptional  Henry G, Garner WL: Inflammatory mediators in wound healing. Surg
              longevity. Ann Intern Med 139:445, 2003.             Clin North Am 83:483, 2003.
           Majno G, Joris I: Apoptosis, oncosis and necrosis: an overview of cell  Martin P: Wound healing—aiming for perfect skin regeneration. Science
              death. Am J Pathol  146: 3, 1995.                    276: 75, 1997.
           Wyllie AH: Apoptosis: In Recent Advances in Histopathology, number  Mott JD, Werb Z: Regulation of matrix biology by matrix
              17, Anthony PP et al (Eds). London, Churchill Livingstone, pp 1,  metalloproteinases. Curr Opin Cell Biol 16:558, 2004.
              1997.
                                                               CHAPTER 7: INFECTIOUS AND PARASITIC DISEASES
           CHAPTER 4: IMMUNOPATHOLOGY INCLUDING
           AMYLOIDOSIS                                         Human plague-United States 1993-94. JAMA 271: 1312, 1994.
                                                               Morens DM et al:  The challenges of emerging and re-emerging
           Centilivre M et al: In HIV –1 pathogenesis, the die is cast during primary  infectious diseases. Nature 430:242, 2004.
              infection. AIDS 21:1, 2007.                      Rappouli R: From Pasteur to genomics: progress and challenges in
           Davidson A, Diamond B: Autoimmune diseases. New Engl J Med 345:  infectious diseases. Nat Med 10:1177, 2004.
              240, 2001.                                       Pasloske BL, Howard RJ: Malaria, the red cell and the endothelium.
           Gonzalez-Scarano F, Martin-Garcia J: The neuropathogenesis of AIDS.  Annu Rev Med 45: 283, 1994.
              Nat Rev Immunol 5:69, 2005.                      Swartz MN: Recognition and management of anthrax—an update. N
           Glenner GG: Amyloid deposits and amyloidosis—the beta fibrillosis. N  Engl J Med 345: 1621, 2001.
              Eng J Med 302: 1283, 1333, 1980.
                                                               Talib VH  et al: Dengue: the killer. Indian J Pathol Microbiol 40(1): 3,
           Guy CD, Jones CK: Abdominal fat pad aspiration biopsy for tissue  1997.
              confirmation of systemic amyloidosis.  Specificity, positive  Talib VH et al: Plague in India (1994): was it really plague in India?
              predictive value and diagnostic pitfalls. Diagn Cytopathol 24: 181,  Indian J Pathol Microbiol 38(2): 131, 1995.
              2001.
           McCune J: The dynamics of CD4+ T-cell depletion in HIV disease.
              Nature 410: 974, 2001.                           CHAPTER 8: NEOPLASIA
           Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N Engl J  Ahr A et al: Identification of high risk breast cancer patients by gene
              Med 349:583, 2003.                                   expression profiling. Lancet 359: 131, 2002.
           Ruiz-Irastorza G et al: Systemic lupus erythematosus. Lancet 357:1027,  Agarwala SS: Paraneoplastic syndromes. Med Clin North Am 80: 173,
              2001.                                                1996.
           Pickens MM: The changing concept of amyloid. Arch Pathol Lab Med  Bertram JS: Molecular biology of cancer. Mol Aspects Med  21: 167,
              125: 38-43, 2001.                                    2001.
           Simon V et al: HIV/AIDS epidemiology, pathogenesis, prevention and  Butel JS: Viral carcinogenesis: revelation of molecular mechanisms
              treatment. Lancet 368:489, 2006.                     and etiology of human disease. Carcinogenesis 21: 405, 2000.
           Sipe JD: Amyloidosis. Crit Rev Clin Lab Sci 31: 325, 1995.  Clemons M, Goss P: Estrogen and the risk of breast cancer. N Engl J
           Stevenson M: HIV-1 pathogenesis. Nat Med 9:853, 2003.   Med 344: 276, 2001.
                                                               Cohen JI: Epstein-Barr virus infections. N Engl J Med 343: 481, 2000.  FURTHER READINGS
           CHAPTER 5: HAEMODYNAMIC DISORDERS                   Eichhorst ST, Krammer PH: Derangement of apoptosis in cancer. Lancet
                                                                   358: 345, 2001.
           Dahlback B: Blood coagulation and its regulation by anticoagulant  Greider CW, Blackburn EH: Telomeres, telomerase and cancer.  Sci
              pathways: genetic pathogenesis of bleeding and thrombotic  Am 274: 92, 1996.
              diseases. J Intern Med 257:209, 2005.
           Evans JJ, Kransz T: Pathogenesis and pathology of shock. In Recent  Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57, 2000.
              Advances in Histopathology, number 16, Anthony PP et al (Eds).  Jiang WG: E-cadherin and its associated protein catenins, cancer
              Philadelphia, Churchill Livingstone, pp 21, 1994.    invasion and metastasis. Br J Surg 83: 437, 1996.
           Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death  Jordan CT, Guzman ML, Noble M: Cancer stem cells. New Engl J Med
              and inflammation in sepsis. Nat Rev Immunol 6:813, 2006.  355:1253, 2006.
           Jarzembowski JA, Young MB: Nontuberculous mycobacterial infections.  Kerbel RS: Tumour angiogenesis: past, present and the near future.
              Arch Pathol Lab Med 132:1333, 2008.                  Carcinogenesis 21: 505, 2000.
           McManus ML et al: Regulation of cell volume in health and disease—  Kustok JL, Wang F: The spectrum of Epstein-Barr associated disease.
              review article. New Engl J Med 333: 1260, 1995.      Annu Rev Pathol Mech Dis 1:375, 2006.
           Mecik BG, Ortel  TL: Clinical and laboratory evaluation of the  Lichtenstein P et al: Environmental  and heritable factors in causation
              hypercoagulable states. Clin Chest Med 16: 375, 1995.  of cancers. N Engl J Med 343: 78, 2000.
           Rosendaal FR: Risk factors for venous thrombosis: prevalence, risk  Pamies RJ. Crawford DR: Tumour markers, an update. Med Clin North
              and interactions. Semin Hematol 34: 171, 1997.       Am 80: 185, 1996.
                                                               Renkvist N et al: A listing of human tumour antigens recognised by T
                                                                   cells. Cancer Immunol Immunother 50: 3, 2001.
           CHAPTER 6: INFLAMMATION AND HEALING
                                                               Rezk SA, Weiss LM: Epstein-Barr virus-associated lympho-
           Baggiolini M: Chemokines in medicine and pathology.  J Intern Med  proliferarative disorders. Hum Pathol 38:1293, 2007.
              250: 90, 2001.                                   Williams GM: Mechanisms of chemical carcinogenesis and application
           Carmeliet P: Angiogenesis in life, disease and medicine.  Nature  to human cancer risk assesssment. Toxicology 166: 3, 2001.
              438:932, 2005.
   916   917   918   919   920   921   922   923   924   925   926